Baird Downgrades Endocyte (ECYT) to Neutral
Tweet
Share
E-mailGet Alerts ECYT Hot Sheet
Price: $23.99 --0%
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 9 | New: 31
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 9 | New: 31
Join SI Premium – FREE
Baird downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral with a price target of $9.00.
For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.
Shares of Endocyte closed at $3.57 yesterday.
For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.
Shares of Endocyte closed at $3.57 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Downgrades Tscan Therapeutics Inc (TCRX) to Neutral
- Berenberg Downgrades DDC Plc. (DCC:LN) (DCCPF) to Hold
- BNP Paribas Exane Downgrades Toast Inc. (TOST) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
